Welcome to PsychU!

Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia

This is a Virtual Event for PsychU members from Connecticut, New Jersey, New York and the Greater California area.

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlates in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.



Elika Hefazi, PharmD, BCPP (OPDC)

Medical Science Liaison


Erika Modh, PharmD, BCPS (OPDC)

Medical Science Liaison

Speakers Elika Hefazi, PharmD, BCPP and Erika Modh, PharmD, BCPS are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)


Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders